TLPH insider trading
NasdaqCM HealthcareTALPHERA, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About TALPHERA, INC.
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Company website: talphera.com
TLPH insider activity at a glance
FilingIQ has scored 84 insider transactions for TLPH since Jan 22, 2024. The most recent filing in our index is dated Apr 2, 2026.
Across the full history, 14 open-market purchases
and 1 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TLPH insider trades is 55.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TLPH Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading TLPH
Frequently asked
- How many insider trades does FilingIQ track for TLPH?
- FilingIQ tracks 84 Form 4 insider transactions for TLPH (TALPHERA, INC.), covering filings from Jan 22, 2024 onwards. 6 of those were filed in the last 90 days.
- Are TLPH insiders net buyers or net sellers?
- Across the full Form 4 history for TLPH, 14 transactions (17%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TLPH insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is TLPH in?
- TALPHERA, INC. (TLPH) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $37.69M.
Methodology & sources
Every TLPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.